RATIOPHARM ApS: Financial statements 2013
CVR: 25762290
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
RATIOPHARM ApS (CVR 25762290) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 328,503 and a net result of DKK 95,633 compared with DKK 513,740 the year before. That is a decrease of 28.1% compared with the year before. Equity in the 2013 report amounted to DKK 1,816,042. The solvency ratio was 87.7%.
- Gross Profit
- DKK 328,503
- Profit/Loss
- DKK 95,633
- Equity
- DKK 1,816,042
- Total Assets
- DKK 2,070,553
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 329 t. | 96 t. | 1.8 mio. | - |
| 2012 | - | 457 t. | 514 t. | 15.9 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
RATIOPHARM ApS has published its annual report for 2012. Gross profit came to DKK 456,801, and the net result was DKK 513,740.
As of April 12, 2013, Betina Liliendal is registered as direktion of RATIOPHARM ApS.
As of April 12, 2013, Peter Mikael Burestedt has stepped down as direktion of RATIOPHARM ApS.
About RATIOPHARM ApS
RATIOPHARM ApS was a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2000. The company has been dissolved on 21 May 2015. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named RATIOPHARM A/S and A/S PSE 17 NR. 1182. The company has 0 employees (2011). In 2013, the company reported a gross profit of DKK 328,503 and a net result of DKK 95,633 compared with DKK 513,740 the year before. Equity in the 2013 report amounted to DKK 1,816,042.